Pages that link to "Q44731832"
Jump to navigation
Jump to search
The following pages link to A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy (Q44731832):
Displaying 50 items.
- Antiepileptic drug monotherapy for epilepsy: a network meta-analysis (Q24187678) (← links)
- Oxcarbazepine for neuropathic pain (Q24198916) (← links)
- Oxcarbazepine versus phenytoin monotherapy for epilepsy (Q24202768) (← links)
- Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures (Q24239996) (← links)
- Oxcarbazepine for neuropathic pain (Q24240708) (← links)
- Comparative monotherapy trials and the clinical treatment of epilepsy (Q24673196) (← links)
- Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia (Q30249421) (← links)
- The promise of new antiepileptic drugs (Q30674774) (← links)
- Management of focal-onset seizures: an update on drug treatment (Q31061153) (← links)
- Monotherapy trials: prerequisite data (Q31934495) (← links)
- Suppressive effects of oxcarbazepine on tooth pulp-evoked potentials recorded at the trigeminal spinal tract nucleus in cats (Q32027306) (← links)
- Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society (Q33202108) (← links)
- Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications (Q33545649) (← links)
- Treatment of epilepsy in the elderly (Q33668889) (← links)
- Monostars: an aid to choosing an antiepileptic drug as monotherapy (Q33756716) (← links)
- Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs (Q33756749) (← links)
- Oxcarbazepine (Q33756777) (← links)
- Predictive value of lidocaine for treatment success of oxcarbazepine in patients with neuropathic pain syndrome (Q33938147) (← links)
- New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety? (Q33949491) (← links)
- Adverse reactions to new anticonvulsant drugs (Q33983920) (← links)
- Newer anticonvulsants: comparative review of drug interactions and adverse effects. (Q33993665) (← links)
- Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials (Q33999456) (← links)
- Current discoveries on the cognitive effects of antiepileptic drugs (Q33999483) (← links)
- Treatment of epilepsy in the multiply handicapped (Q34099234) (← links)
- Strategies for optimizing antiepileptic drug therapy in elderly people (Q34118987) (← links)
- Choice and use of newer anticonvulsant drugs in older patients (Q34152772) (← links)
- New anti-epileptic drugs for the 21st century (Q34182061) (← links)
- Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations (Q34186198) (← links)
- Efficacy, pharmacology, and adverse effects of antiepileptic drugs (Q34254760) (← links)
- Pharmacologic management of epilepsy in the elderly. (Q34261443) (← links)
- Oxcarbazepine, an antiepileptic agent (Q34275202) (← links)
- Oxcarbazepine: an update of its efficacy in the management of epilepsy (Q34312353) (← links)
- The star systems: overview and use in determining antiepileptic drug choice (Q34314537) (← links)
- The management of refractory idiopathic epilepsies (Q34345026) (← links)
- A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients (Q34345926) (← links)
- Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine. (Q34358782) (← links)
- Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view (Q34364855) (← links)
- Life-threatening adverse events of antiepileptic drugs (Q34416456) (← links)
- Oxcarbazepine in the treatment of epilepsy (Q34445634) (← links)
- Treating epilepsy in the elderly: safety considerations (Q34458573) (← links)
- Appropriate use of medications for seizures. Guiding principles on the path of efficacy (Q34505848) (← links)
- Effects of oxcarbazepine on sodium concentration and water handling (Q34525209) (← links)
- Second generation anticonvulsant medications: their use in children (Q34555652) (← links)
- What can we learn from clinical trials of anticonvulsant drugs in epilepsy? (Q34558531) (← links)
- Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: a comparative review of newer versus older agents. (Q34563059) (← links)
- New antiepileptic drugs: comparative studies of efficacy and cognition (Q34566302) (← links)
- Three new drugs for epilepsy: levetiracetam, oxcarbazepine, and zonisamide (Q34579452) (← links)
- Using the new antiepilepsy drugs in children (Q34579459) (← links)
- An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy (Q34590272) (← links)
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial (Q34611908) (← links)